July 9, 2025

Targeting proteostasis in multiple myeloma through inhibition of LTK – Leukemia – Nature

July 8, 2025

FDA Removes REMS Requirements for CAR T

If you or a loved one has been exploring treatment options for relapsed or refractory multiple myeloma, you may have heard of CAR T-cell therapy—a highly effective treatment option that reprograms your own immune system to fight cancer. In a pivotal move, the FDA recently removed the Risk Evaluation and Mitigation Strategy (REMS) requirements for […]

July 7, 2025

EHA–EMN Evidence-Based Guidelines for diagnosis, treatment and follow-up of patients with multiple myeloma – Nature

June 24, 2025

Why transplant should be considered earlier for multiple myeloma patients – Roswell Park Comprehensive Cancer Center

June 18, 2025

Multiple myeloma – Johnson & Johnson